Dr Kelvin Stott – Founder & CEO
Pharma R&D portfolio leader, entrepreneur, visionary 20+ years in Pharma (Novartis, Merck Serono), biotech (CSL, Sensyne, Senexis), business consulting (McKinsey, PwC, Quantelium) and venture capital (Inventages)Former Head of R&D Portfolio Management at CSLFormer founder & CSO at Senexis (same disease focus)Post-doc Research Fellow and PhD at Cambridge
Dr Hervé Schaffhauser – CSO / SVP Biology
Neuropharmacologist, translational neuroscience leader20+ years in Pharma (Roche, Merck) and biotech (Coave, Versameb, Preciphos, Cephalon)Former Director of Translational Neuroscience at CoaveLed discovery and preclinical development of CNS drugs from target validation into Phase 1 trialsPost-doc at Emory, PhD at Louis Pasteur University
Dr Daniel Umbricht – CMO / SVP Clinical
Senior clinical development leader in neuroscience30+ years in Pharma (Roche, Novartis), biotech (Autifony, Gilgamesh), clinical practice (University of Zurich, Long Island JMC, Albert Einstein College of Medicine, etc.) and consulting (Xperimed)Former Head of Translational Medicine at RocheAssociate Professor and MD at University of Zurich